RPRX
Royalty Pharma plc
Stock
$57.16−0.47 (−0.82%)Close Oct 2, 2026
- Revenue, 2025
- $2.4B
- YoY, 2025
- +5.1%
- 5-year CAGR
- +2.3%
Revenue
Revenue by fiscal year
| Period | Revenue | YoY |
|---|---|---|
| 2025 | $2.4B | +5.1% |
| 2024 | $2.3B | −3.9% |
| 2023 | $2.4B | +5.2% |
| 2022 | $2.2B | −2.3% |
| 2021 | $2.3B | +7.9% |
| 2020 | $2.1B | +17.0% |
| 2019 | $1.8B | +1.1% |
| 2018 | $1.8B | — |